Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 7/20 | 0.55 |
| ▸ | SLC6A4 | P31645 | 7/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 7/20 | 0.55 |
| ▸ | MEN1 | O00255 | 5/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.51 |
| ▸ | MTOR | P42345 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | MLNR | O43193 | 1/20 | 0.51 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.51 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.51 |
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.51 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.51 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.51 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8254519 | 1.00 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3MEN1KMT2A | |
| SCHEMBL4288613 | 1.00 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL5348264 | 0.99 | SLC6A2 (0.53) | SLC6A2SLC6A4SLC6A3MEN1KMT2A | |
| SCHEMBL9843161 | 0.86 | SLC6A2 (0.57) | SLC6A2SLC6A4SLC6A3MEN1KMT2A | |
| SCHEMBL17199773 | 0.84 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3MEN1KMT2A | |
| SCHEMBL8814001 | 0.82 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL10989854 | 0.80 | HTR2A (0.45) | SLC6A2MEN1KMT2ACYP3A4CYP2C19 | |
| SCHEMBL5309256 | 0.79 | HTR2A (0.42) | SLC6A2SLC6A3MEN1KMT2ACYP3A4 | |
| SCHEMBL3363271 | 0.78 | SLC6A2 (0.48) | SLC6A2SLC6A4SLC6A3MEN1KMT2A | |
| SCHEMBL19775842 | 0.77 | SLC6A4 (0.47) | SLC6A2SLC6A4SLC6A3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1224159-A1 | IMPROVED SYNTHESIS OF RACEMIC SERTRALINE | A/S GEA Farmaceutisk Fabrik (DK) | 2002-07-24 | — | — | EP | claimed |
| WO-2001072684-A1 | PROCESS FOR THE PREPARATION OF POLYMORPH OF 4-(ARYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE DERIVATIVE | SUN PHARMACEUTICAL INDUSTRIES LTD. (IN) | 2001-10-04 | — | — | WO | claimed |
| WO-2001030742-A1 | IMPROVED SYNTHESIS OF RACEMIC SERTRALINE | A/S GEA FARMACEUTISK FABRIK (DK) | 2001-05-03 | — | — | WO | claimed |
| EP-0386117-A1 | TREATING PREMENSTRUAL OR LATE LUTEAL PHASE SYNDROME | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1990-09-12 | — | — | EP | claimed |
| WO-1989003692-A1 | TREATING PREMENSTRUAL OR LATE LUTEAL PHASE SYNDROME | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1989-05-05 | — | — | WO | claimed |
| US-20110200587-A1 | AMINOTHIAZOLONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2011-08-18 | — | — | US | disclosed |
| US-7390847-B2 | Polymer derivatives for the treatment of metals | BASF SE (DE) | 2008-06-24 | — | — | US | disclosed |
| US-20050121114-A1 | Polymer derivatives for the treatment of metals | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-09 | — | — | US | disclosed |
| WO-2001049638-A2 | A PROCESS FOR CONVERTING STEREOISOMERS OF SERTRALINE INTO SERTRALINE | SUN PHARMACEUTICAL INDUSTRIES LTD. (IN) | 2001-07-12 | — | — | WO | disclosed |
| EP-1047666-A1 | NOVEL PROCESS FOR PREPARING A KETIMINE | Pfizer Products Inc. (US) | 2000-11-02 | — | — | EP | disclosed |
| US-6022522-A | DETECTABLY LABELED BICONJUGATE COMPOUND WHICH COMPRISES A MONOCLONAL ANTIBODY AND A TECHTINIUM-99M COUPLED TO A CHELATING AGENT HAVING A RIGID CYCLIC HYDROCARBON BACKBONE OF GIVEN FORMULA, COUPLED TO THE MONOCLONAL ANTIBODY | BROOKHAVEN SCIENCE ASSOCIATES (US) | 2000-02-08 | — | — | US | disclosed |
| WO-1999057093-A1 | PROCESS FOR THE PREPARATION OF SERTRALINE AND ITS 1,R-STEREOISOMER | EGIS Gyógyszergyár Rt. (HU) | 1999-11-11 | — | — | WO | disclosed |
| WO-1999036394-A1 | NOVEL PROCESS FOR PREPARING A KETIMINE | PFIZER PRODUCTS INC. (US) | 1999-07-22 | — | — | WO | disclosed |
| EP-0575507-A1 | PROCESS FOR RECYCLING AMINE ISOMER. | PFIZER (US) | 1993-12-29 | — | — | EP | disclosed |
| WO-1992015552-A1 | PROCESS FOR RECYCLING AMINE ISOMER | PFIZER INC. (US) | 1992-09-17 | — | — | WO | disclosed |
| EP-0295050-A1 | Process for preparing a 4,4-diphenylbutanoic acid derivative | PFIZER INC. (US) | 1988-12-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110200587-A1 | AMINOTHIAZOLONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS | ESR2, ESRRA, ESRRG | SLC6A2 3985/4885SLC6A4 3984/4885SLC6A3 3581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.